Evidence map›Paper›PMID 40998034›Full record

ArticleJournal of lipid research2025

Spatial lipidomics reveals demyelination and remyelination dynamics in the mouse brain.

Mikolaj Opielka, Krzysztof Urbanowicz, Klaudia Konieczna-Wolska, Elisabeth Müller, Oliwier Krajewski, Maureen Feucherolles, Qiuqin Zhou, Michal Bienkowski, Gilles Frache, Carsten Hopf and 3 more

Abstract read
In one paragraph

Article in Journal of lipid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mikolaj OpielkaDepartment of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Krzysztof UrbanowiczDepartment of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Klaudia Konieczna-WolskaTri-City Central Animal Laboratory Research and Service Center, Medical University of Gdansk, Gdansk, Poland.
Elisabeth MüllerCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany; Medical Faculty, Heidelberg University, Heidelberg, Germany.
Oliwier KrajewskiDepartment of Anatomy and Neurobiology, Medical University of Gdansk, Gdansk, Poland.
Maureen FeucherollesLuxembourg Institute of Science and Technology (LIST), Advanced Instrumentation and Nano-Analytics, Belvaux, Luxembourg.
Qiuqin ZhouCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.
Michal BienkowskiDepartment of Pathomorphology, Medical University of Gdansk, Gdansk, Poland.
Gilles FracheLuxembourg Institute of Science and Technology (LIST), Advanced Instrumentation and Nano-Analytics, Belvaux, Luxembourg.
Carsten HopfCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany; Medical Faculty, Heidelberg University, Heidelberg, Germany; Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Lucas SchirmerMannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Department of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Interdisciplinary Center for Neurosciences, Heidelberg University, Heidelberg, Germany.
Aleksandra RutkowskaDepartment of Anatomy and Neurobiology, Medical University of Gdansk, Gdansk, Poland; Brain Diseases Centre, Medical University of Gdansk, Gdansk, Poland. Electronic address: ola.rutkowska@gumed.edu.pl.
Ryszard T SmolenskiDepartment of Biochemistry, Medical University of Gdansk, Gdansk, Poland. Electronic address: rt.smolenski@gumed.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelin pathology in demyelinating diseases is accompanied by lipid remodeling that remains challenging to characterize at the spatial level using traditional mass spectrometry. We developed an optimized AP-MALDI-Orbitrap MSI pipeline, incorporating sample preparation improvements and mass recalibration, to investigate lipid dynamics in the cuprizone (CPZ) mouse model of demyelination. Dual-modality, untargeted lipid profiling was performed to map spatially resolved lipid alterations during demyelination and spontaneous remyelination in two key brain areas of male mice: corpus callosum (CC) and cortex (Ctx), with lipid identifications benchmarked against 4D-LC-TIMS-MS/MS. Demyelinated regions were identified using Black Gold II staining. Using 1 ppm mass tolerance, we annotated 154 and 133 lipids at the sum-composition level in CC and Ctx, respectively, with 60% validated by LC-MS/MS. Spatial lipid profiling revealed CPZ-induced alterations in sphingolipids, sulfatides, and glycerophospholipids, supported by reanalysis of a published snRNA-seq dataset from a mouse CPZ model. Long-chain ceramides (Cer) and hexosylceramides (HexCer) were reduced in demyelinated regions, with partial, region-specific recovery during remyelination. Short-chain sulfatides (SHexCer), sphingomyelins (SM), and seminolipids transiently increased in the CC during demyelination, while long-chain sulfatides decreased in both CC and Ctx. Additionally, we observed demyelination-induced upregulation of polyunsaturated glycerophospholipids in CC and phosphatidylinositols (PI) in cortex. Lipid subclass changes emerged as reliable markers of both demyelination and remyelination in the mouse brain. Region-specific alterations in lipid metabolism provide new insights into the processes of de- and remyelination. Notably, remyelinated fibers have a distinct lipid profile compared to intact myelin, suggesting that lipid-based therapeutic strategies could improve myelin repair.

Indexed as

BrainDemyelinating DiseasesLipidomicsMyelin SheathRemyelinationAnimalsCorpus CallosumCuprizoneDisease Models, AnimalLipid MetabolismMaleMiceMice, Inbred C57BLCuprizone4D-LC-TIMS-MSAP-MALDI-MSIbrain lipidscuprizone modeldemyelinationglycolipidsmass spectrometry imagingremyelinationspatial lipidomicssphingolipids

Identifiers

PMID40998034
PMCPMC12684768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.